<SEC-DOCUMENT>0001654954-18-001133-index.html : 20180206 <SEC-HEADER>0001654954-18-001133.hdr.sgml : 20180206 <ACCEPTANCE-DATETIME>20180206172957 ACCESSION NUMBER: 0001654954-18-001133 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: <ITEMS>06b FILED AS OF DATE: 20180206 DATE AS OF CHANGE: 20180206 EFFECTIVENESS DATE: 20180206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GT Biopharma, Inc. CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-304968 FILM NUMBER: 18578615 BUSINESS ADDRESS: STREET 1: 1825 K STREET STREET 2: SUITE 510 CITY: WASHINGTON, D.C. STATE: DC ZIP: 33602 BUSINESS PHONE: (800) 304-9888 MAIL ADDRESS: STREET 1: 1825 K STREET STREET 2: SUITE 510 CITY: WASHINGTON, D.C. STATE: DC ZIP: 33602 FORMER COMPANY: FORMER CONFORMED NAME: OXIS INTERNATIONAL INC DATE OF NAME CHANGE: 19940916 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 </SEC-HEADER> <DOCUMENT> <TYPE>D <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> </SEC-DOCUMENT>